Overtreatment by hysterectomy for cervical intraepithelial neoplasia: Medico-legal Aspects

Abstract

The article abstract is not available

References
[1] Ciavattini A, Di Giuseppe J, Marconi C, Giannella L, Delli Carpini G, Paolucci M, et al. Hysterectomy for cervical intraepithelial neoplasia: A retrospective observational multi-institutional study. Int J Gynaecol Obstet 2022; 159: 679–688.

[2] World Health Organization. WHO guidelines for treatment of cervical intraepithelial neoplasia 2-3 and adenocarcinoma in situ. Switzerland: World Health Organization Press; 2014.

[3] Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder Ch, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Virchows Arch 2018; 472: 919–936.

[4] Berek JS. Berek & Novak’s gynecology. 16th Ed. Philadelphia: Wolters Kluwer Health; 2019.

[5] Cioffi A, Cioffi F. A culture of openness and defensive medicine. Health Aff 2019; 38: 1411-1412.

[6] Laughlin-Tommaso SK, Satish A, Khan Z, Smith CY, Rocca WA, Stewart EA. Long-term risk of de novo mental health conditions after hysterectomy with ovarian conservation: A cohort study. Menopause 2020; 27: 33–42.